EIGR
Eiger BioPharmaceuticals, Inc.
EIGR
EIGR
Delisted
EIGR was delisted on the 10th of April, 2024.
39 hedge funds and large institutions have $39.6M invested in Eiger BioPharmaceuticals, Inc. in 2017 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 10 increasing their positions, 8 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
39
Holders Change
-6
Holders Change %
-13.33%
% of All Funds
0.97%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.05%
New
11
Increased
10
Reduced
8
Closed
17
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
HP
1
Hikari Power
Tokyo,
Japan
|
$482K |
| 2 |
2
Millennium Management
New York
|
$365K |
| 3 |
BCM
3
Bridgeway Capital Management
Houston,
Texas
|
$553K |
| 4 |
4
Goldman Sachs
New York
|
$272K |
| 5 |
5
Renaissance Technologies
New York
|
$185K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
CG
51
Cutler Group
San Francisco,
California
| – | -$12K | -38 | Closed |
|
52
Legal & General Group
London,
United Kingdom
| – | -$10K | -31 | Closed |
|
|
QCG
53
Quadrant Capital Group
Cincinnati,
Ohio
| – | -$4K | -14 | Closed |
|
|
AIP
54
Ameritas Investment Partners
Lincoln,
Nebraska
| – | -$3K | -9 | Closed |
|
55
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$2K | -5 | Closed |
|
|
MIM
56
Monashee Investment Management
Boston,
Massachusetts
| – | -$361K | – | – |
|